Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-02T19:40:47.216Z.
Calculation as of: 2026-10-02T19:40:47.216Z.
Quote observation: 2026-10-02T19:40:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dd069712ede8f4b2ce64df8e3e19fb9c01fcfd31feb2761ca66e255950af83c7
PEG RATIO
N/A
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
N/A
PEG RATIO AVG 5Y
N/A
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $472.39M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $459.30M | N/A | 6.07 | 3.14 | 2.42 |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | N/A | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | N/A | 6.61 | 5.90 | 4.86 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2020-07-31 | 7.19 |
| 2020-07-30 | 7.21 |
| 2020-07-29 | 7.06 |
| 2020-07-28 | 6.73 |
| 2020-07-27 | 6.92 |
| 2020-07-24 | 6.77 |
| 2020-07-23 | 6.90 |
| 2020-07-22 | 6.91 |
| 2020-07-21 | 6.87 |
| 2020-07-20 | 6.98 |
| 2020-07-17 | 6.84 |
| 2020-07-16 | 6.84 |
| 2020-07-15 | 6.86 |
| 2020-07-14 | 6.64 |
| 2020-07-13 | 6.58 |
| 2020-07-10 | 6.74 |
| 2020-07-09 | 6.83 |
| 2020-07-08 | 6.79 |
| 2020-07-07 | 6.65 |
| 2020-07-06 | 6.53 |
| 2020-07-02 | 6.37 |
| 2020-07-01 | 6.25 |
| 2020-06-30 | 5.82 |
| 2020-06-29 | 5.48 |
| 2020-06-26 | 5.13 |
| 2020-06-25 | 5.51 |
| 2020-06-24 | 5.22 |
| 2020-06-23 | 5.45 |
| 2020-06-22 | 5.37 |
| 2020-06-19 | 5.33 |
| 2020-06-18 | 5.31 |
| 2020-06-17 | 5.17 |
| 2020-06-16 | 5.36 |
| 2020-06-15 | 5.29 |
| 2020-06-12 | 5.08 |
| 2020-06-11 | 4.87 |
| 2020-06-10 | 5.19 |
| 2020-06-09 | 5.22 |
| 2020-06-08 | 5.24 |
| 2020-06-05 | 5.18 |
| 2020-06-04 | 5.17 |
| 2020-06-03 | 5.12 |
| 2020-06-02 | 4.94 |
| 2020-06-01 | 4.82 |
| 2020-05-29 | 5.02 |
| 2020-05-28 | 5.20 |
| 2020-05-27 | 5.37 |
| 2020-05-26 | 5.12 |
| 2020-05-22 | 5.30 |
| 2020-05-21 | 5.23 |
| 2020-05-20 | 5.28 |
| 2020-05-19 | 5.18 |
| 2020-05-18 | 5.33 |
| 2020-05-15 | 5.33 |
| 2020-05-14 | 5.22 |
| 2020-05-13 | 5.09 |
| 2020-05-12 | 5.06 |
| 2020-05-11 | 5.29 |
| 2020-05-08 | 5.28 |
| 2020-05-07 | 5.19 |
| 2020-05-06 | 5.24 |
| 2020-05-05 | 5.14 |
| 2020-05-04 | 4.84 |
| 2020-05-01 | 4.89 |
| 2020-04-30 | 5.14 |
| 2020-04-29 | 2.68 |
| 2020-04-28 | 2.42 |
| 2020-04-27 | 2.62 |
| 2020-04-24 | 2.57 |
| 2020-04-23 | 2.45 |
| 2020-04-22 | 2.39 |
| 2020-04-21 | 2.37 |
| 2020-04-20 | 2.47 |
| 2020-04-17 | 2.53 |
| 2020-04-16 | 2.43 |
| 2020-04-15 | 2.38 |
| 2020-04-14 | 2.48 |
| 2020-04-13 | 2.38 |
| 2020-04-09 | 2.34 |
| 2020-04-08 | 2.26 |
| 2020-04-07 | 2.16 |
| 2020-04-06 | 2.26 |
| 2020-04-03 | 2.09 |
| 2020-04-02 | 2.33 |
| 2020-04-01 | 2.27 |
| 2020-03-31 | 2.38 |
| 2020-03-30 | 2.39 |
| 2020-03-27 | 2.22 |
| 2020-03-26 | 2.35 |
| 2020-03-25 | 2.28 |
| 2020-03-24 | 2.34 |
| 2020-03-23 | 2.09 |
| 2020-03-20 | 2.20 |
| 2020-03-19 | 2.31 |
| 2020-03-18 | 2.15 |
| 2020-03-17 | 2.08 |
| 2020-03-16 | 1.77 |
| 2020-03-13 | 2.21 |
| 2020-03-12 | 2.07 |
| 2020-03-11 | 2.14 |
| 2020-03-10 | 2.42 |
| 2020-03-09 | 2.36 |
| 2020-03-06 | 2.51 |
| 2020-03-05 | 2.64 |
| 2020-03-04 | 2.70 |
| 2020-03-03 | 2.59 |
| 2020-03-02 | 2.55 |